Founder and CEO
Northwind Pharmaceuticals
Phillip Berry is the Founder & CEO of Northwind Pharmaceuticals, a fast-growing provider of health claims analytics, medications onsite and at home, pharmacy administrative services, and clinical programs, that decrease costs and improve health outcomes for self-funded employers. He is also the author of Nexus of Care: Fulfilling the Promise of Employer-Sponsored Health Centers - a book offering self-funded employers an actionable strategy for influencing employee health costs and outcomes.
Improving access and outcomes while lowering costs.
Clinical blueprints for effective population health management. New technology to bridge knowledge gaps in health spend and population health strategy.
Costs and care. We bring a stewardship-driven, transparent model to Rx access and pair it with clinical blueprints to leverage drug spend to impact high cost chronic disease.
Rx and hospital care.
Yes. Rx and diabetes management.
I don't think virtual is a stand alone solution for care - it must be married with great access.
In this session, panelists will take the audience on a journey through the development and implementation of a collaborative care strategy via worksite health centers. Through real examples, patient stories, lessons learned, and actual results, attendees will learn the ‘why’ behind the ‘what’ and how they can leverage a different approach to employee health – one that actually reduces costs while improving health outcomes.
View session detailsRemember the mission to reach the moon? In 1962, President JFK set forth a vision. He initiated a movement that outlived him! Even in his death, the mission was accomplished seven years after his famous speech. Now we’re on a five-year mission, and it's not about us. This is a mission for you – the individual, the stakeholder, the employer healthcare and benefits professional. Join the mission to reduce costs, reimagine culture, and reinvent care.
Care
Moonshot #3
Provide 40% of healthcare services virtually and through technology by 2025.